K-V subsidiary relaunches bacterial vaginosis drug
ST. LOUIS — A new treatment for bacterial infections of the vagina is now available, the drug’s manufacturer said Monday.
K-V Pharmaceutical Co. subsidiary Ther-Rx Corp. announced the availability of Clindesse (clindamycin phosphate), saying wholesalers have ordered and received it and are distributing it to retail pharmacies. The drug is used to treat bacterial vaginosis in women who are not pregnant. BV results from an overgrowth of several bacterial species and is the most common vaginal infection in women of childbearing age.
"We are pleased to be able to once again offer Clindesse," K-V CEO Greg Divis said. "Together with Gyanzole-1’s reintroduction in January, the availability of Clindesse represents a key positive milestone for the company as the two products comprising our anti-infectives franchise are both available for prescribing."
Clindesse was removed from the market in 2009 following action by the Food and Drug Administration barring K-V from selling or distributing drugs due to manufacturing issues and the marketing of products that had not received FDA approval. The drug was originally approved in 2004.
Softlips introduces lip balm with breath-freshening flavor technology
ORCHARD PARK, N.Y. — Softlips lip balm announced today the company will offer an innovative twist on lip hydration with the brand’s latest portfolio addition. New Softlips Intense Moisture, a cutting-edge lip balm that saturates lips with moisture while breath freshening technology adds a minty flavor.
The Intense Moisture lip balm line will debut in cough and cold aisles in major retailer locations nationwide September 2013.
"As part of our commitment to exceed consumers’ needs and stay true to Softlips’ long legacy of flavorful lip balms, we were inspired to create a new generation of Softlips lip balm," says Katherine Tocheff, Director of Marketing and Innovation Skin Care and Lip Care, The Mentholatum Company, a division of Rohto Pharmaceutical Co., Ltd. "Giving the consumer a richly moisturizing formula that restores softness and hydration to even the driest lips while taking our signature flavor expertise to the next level."
Softlips Intense Moisture lip balm is available in three flavors: Softlips Berry Mint, Softlips Citrus Mint and Softlips Double Mint.
In addition, Softlips is providing the consumer more ways to "hydrate deliciously" with additions to the 2013 summer product line up. Softlips Flavor Fusions coupled with new and improved Softlips Tints will be sold at Ulta Beauty.
Like this story? Find us on Facebook for more insight, analysis and the latest in drug store news. Join the conversation.
Electronic medical records boost patient satisfaction, loyalty, study finds
CHICAGO — Nearly a quarter of Americans are using electronic medical records for checking test results, refilling prescriptions and making appointments, while more than half say they would like to use them, but don’t have access, according to a new study.
The study, by Aeffect and 88 Brand Partners, included 1,000 respondents ages 25 years to 55 years, finding that 24% of them used EMRs, while 52% would like to. At the same time, nearly half of patients take EMR access into consideration when choosing a healthcare provider.
Under the American Recovery and Reinvestment Act of 2009, physicians who have not adopted EMRs by 2015 will have their Medicare reimbursements reduced by 1%, with an additional 1% reduction each year through 2017 and an annual 3% reduction afterward. According to a study by the Robert Wood Johnson Foundation, Harvard School of Public Health and Mathematica Research, the percentage of physicians using EMR has increased from almost 26% in 2010 to more than 38% last year.
Overall, 78% of patients using EMRs expressed satisfaction with their physicians, compared with 68% not using them, as well as higher satisfaction across multiple dimensions of care, such as ease of access to information, clarity and thoroughness of communication and stronger loyalty to their doctors.